A pilot study of risk-stratified cervical cancer screening.
Jiangrong Wang, K Miriam Elfström, Christer Borgfeldt...
https://pubmed.ncbi.nlm.nih.gov/37645164/Actively Recruiting
Led by Karolinska Institutet · Updated on 2025-01-14
20000
Participants Needed
6
Research Sites
N/A
Total Duration
Researchers are evaluating new ways to increase participation in cervical cancer screening among women at higher risk due to missed follow-ups or irregular attendance. This study focuses on women identified through registry data who may benefit from reminders sent via SMS, electronic letters, or physical letters. Cervical cancer screening has been highly successful in Sweden, preventing many cases, but non-participation remains a significant risk factor for developing the disease. The study sends invitations and reminders using different methods and offers self-sampling kits for HPV testing either by direct mailing or through an online ordering system. The sampling kits include instructions and a prepaid envelope for returning samples. The collected samples are analyzed for HPV types associated with cervical cancer using approved molecular tests, with the testing platform updated in 2022. Follow-up procedures vary based on risk, including direct referrals for women with positive HPV results and reassuring messages for those testing negative. Participants are monitored for their response to invitations over a 12-month period. Researchers measure participation rates, the number of positive HPV screens, and rates of precursors and cases of cervical cancer. The study is conducted nationally with annual identification of women at elevated risk, and follow-up is coordinated through regional contacts. The study began in 2019 and aims to assess whether modern communication methods can improve screening attendance and early detection.
CONDITIONS
Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer.
M
Miriam Elfström, PhD
H
Helena Andersson, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Karolinska Institutet
Lead Sponsor
Region Skane
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit (remote communication via SMS or electronic letter)
Duration - Up to 12 months after the invitation
Participants receive invitations to order an HPV self-sampling test through SMS or electronic letters, and samples are submitted for HPV testing as part of cervical cancer prevention.
No in-person visits; participation involves submitting self-sampling kits by mail
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Jiangrong Wang, K Miriam Elfström, Christer Borgfeldt...
https://pubmed.ncbi.nlm.nih.gov/37645164/Laila Sara Arroyo Mühr, Jiangrong Wang, Sadaf S Hassan...
https://pubmed.ncbi.nlm.nih.gov/39146489/Klara Miriam Elfström, Karin Sundström, Sonia Andersson...
https://pubmed.ncbi.nlm.nih.gov/31032904/Karolinska Institutet
Lead Sponsor
Region Skane
Collaborating Sponsor